ACAD
Price
$25.52
Change
-$0.70 (-2.67%)
Updated
Jul 13, 11:45 AM (EDT)
Capitalization
4.49B
29 days until earnings call
Intraday BUY SELL Signals
CCCC
Price
$3.99
Change
-$0.07 (-1.72%)
Updated
Jul 13, 11:47 AM (EDT)
Capitalization
448.9M
30 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACAD vs CCCC

ACAD vs CCCC Comparison Chart in %
View a ticker or compare two or three
VS
ACAD vs. CCCC commentary
Jul 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Buy and CCCC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 13, 2026
Stock price -- (ACAD: $26.22 vs. CCCC: $4.06)
Brand notoriety: ACAD and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 58% vs. CCCC: 84%
Market capitalization -- ACAD: $4.49B vs. CCCC: $448.9M
ACAD [@Biotechnology] is valued at $4.49B. CCCC’s [@Biotechnology] market capitalization is $448.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $123.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 1 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • ACAD’s FA Score: 1 green, 4 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, ACAD is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 6 TA indicator(s) are bullish while CCCC’s TA Score has 3 bullish TA indicator(s).

  • ACAD’s TA Score: 6 bullish, 3 bearish.
  • CCCC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ACAD is a better buy in the short-term than CCCC.

Price Growth

ACAD (@Biotechnology) experienced а +0.96% price change this week, while CCCC (@Biotechnology) price change was -5.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.42%. For the same industry, the average monthly price growth was +13.23%, and the average quarterly price growth was +1883.80%.

Reported Earning Dates

ACAD is expected to report earnings on Aug 11, 2026.

CCCC is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-0.42% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACAD($4.49B) has a higher market cap than CCCC($449M). CCCC YTD gains are higher at: 112.565 vs. ACAD (-1.835). ACAD has higher annual earnings (EBITDA): 92.7M vs. CCCC (-101.2M). ACAD has more cash in the bank: 851M vs. CCCC (236M). ACAD has less debt than CCCC: ACAD (50.8M) vs CCCC (58.4M). ACAD has higher revenues than CCCC: ACAD (1.1B) vs CCCC (34.9M).
ACADCCCCACAD / CCCC
Capitalization4.49B449M1,000%
EBITDA92.7M-101.2M-92%
Gain YTD-1.835112.565-2%
P/E Ratio11.86N/A-
Revenue1.1B34.9M3,138%
Total Cash851M236M361%
Total Debt50.8M58.4M87%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
26
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADCCCC
RSI
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
68%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 18 days ago
74%
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ACAD
Daily Signal:
Gain/Loss:
CCCC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NAIL42.101.09
+2.66%
Direxion Daily Hmbldrs&Supls Bull 3X ETF
EWT106.191.14
+1.09%
iShares MSCI Taiwan ETF
IOPP26.500.21
+0.80%
Simplify Tara India Opportunities ETF
NMT12.800.10
+0.79%
Nuveen Massachusetts Quality Municipal Income Fund
DDTO23.080.05
+0.22%
Innovator Eq Dual Drctnl 10 Buf ETF Oct

ACAD and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACAD has been loosely correlated with DNLI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ACAD jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACAD
1D Price
Change %
ACAD100%
-0.72%
DNLI - ACAD
40%
Loosely correlated
-5.62%
STTK - ACAD
39%
Loosely correlated
-5.55%
HRMY - ACAD
39%
Loosely correlated
-3.59%
CLDX - ACAD
38%
Loosely correlated
+0.33%
RXRX - ACAD
37%
Loosely correlated
-5.32%
More

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with AXON. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-5.36%
AXON - CCCC
40%
Loosely correlated
-2.78%
CELC - CCCC
38%
Loosely correlated
-5.22%
REPL - CCCC
35%
Loosely correlated
-1.08%
WVE - CCCC
35%
Loosely correlated
-0.95%
ARRY - CCCC
35%
Loosely correlated
-1.39%
More